Time-lapse imaging reveals differences in growth dynamics of embryos after in vitro maturation compared with conventional stimulation

Fertility and Sterility

Volumn 107, Issue 3, 2017, Pages 606-612.e3

  Roesner, Sabine ^a   Dietrich, Jens Erik ^a   Weigert, Julia ^a   Montag, Markus ^b   Toth, Bettina ^c   Strowitzki, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Ilabcomm GmbH   (Germany)

^c Gynecologic Endocrinology and Reproductive Medicine   (Austria)

Author keywords

clinical pregnancy rate; in vitro maturation; morphokinetic parameters; Time lapse imaging

Indexed keywords

MUELLERIAN INHIBITING FACTOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYO GROWTH; EMBRYO TRANSFER; FEMALE; HORMONE DETERMINATION; HUMAN; IN VITRO OOCYTE MATURATION; INTERMETHOD COMPARISON; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; OVARY POLYCYSTIC DISEASE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME LAPSE IMAGING; UNIVERSITY HOSPITAL; ADULT; BLASTOCYST; COMPLICATION; FERTILITY; INFERTILITY; KINETICS; MEIOSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PROCEDURES; TREATMENT OUTCOME; VIDEO MICROSCOPY; YOUNG ADULT;

ADULT; BLASTOCYST; EMBRYO CULTURE TECHNIQUES; EMBRYO TRANSFER; EMBRYONIC DEVELOPMENT; FEMALE; FERTILITY; HOSPITALS, UNIVERSITY; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; INFERTILITY; KINETICS; LIVE BIRTH; MEIOSIS; MICROSCOPY, VIDEO; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; TIME-LAPSE IMAGING; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85010888142     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2016.12.026     Document Type: Article

References (44)

1. 1 Roesner, S., von Wolff, M., Eberhardt, I., Beuter-Winkler, P., Toth, B., Strowitzki, T., In vitro maturation: a five-year experience. Acta Obstet Gynecol Scand 91 (2012), 22–27.
2. 2 Das, M., Son, W.Y., Buckett, W., Tulandi, T., Holzer, H., In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome. Reprod Biomed Online 29 (2014), 545–551.
3. 3 Guzman, L., Ortega-Hrepich, C., Polyzos, N.P., Anckaert, E., Verheyen, G., Coucke, W., et al. A prediction model to select PCOS patients suitable for IVM treatment based on anti-müllerian hormone and antral follicle count. Hum Reprod 28 (2013), 1261–1266.
4. 4 Wissing, M.L., Bjerge, M.R., Olesen, A.I., Hoest, T., Mikkelsen, A.L., Impact of PCOS on early embryo cleavage kinetics. Reprod Biomed Online 28 (2014), 508–514.
5. 5 Wood, J.R., Dumesic, D.A., Abbott, D.H., Strauss, J.F. 3rd, Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 92 (2007), 705–713.
6. 6 Teixeira Filho, F.L., Baracat, E.C., Lee, T.H., Suh, C.S., Matsui, M., Chang, R.J., et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002), 1337–1344.
7. 7 Pribenszky, C., Matyas, S., Kovacs, P., Losonczi, E., Zadori, J., Vajta, G., Pregnancy achieved by transfer of a single blastocyst selected by time-lapse monitoring. Reprod Biomed Online 21 (2010), 533–536.
8. 8 Meseguer, M., Herrero, J., Tejera, A., Hilligsoe, K.M., Ramsing, N.B., Remohi, J., The use of morphokinetics as a predictor of embryo implantation. Hum Reprod 26 (2011), 2658–2671.
9. 9 Meseguer, M., Rubio, I., Cruz, M., Basile, N., Marcos, J., Requena, A., Embryo incubation and selection in a time-lapse monitoring system improves pregnancy outcome compared with a standard incubator: a retrospective cohort study. Fertil Steril 98 (2012), 1481–1489.e10.
10. 10 Rubio, I., Galan, A., Larreategui, Z., Ayerdi, F., Bellver, J., Herrero, J., et al. Clinical validation of embryo culture and selection by morphokinetic analysis: a randomized, controlled trial of the Embryoscope. Fertil Steril 102 (2014), 1287–1294.e5.
11. 11 Walls, M.L., Hunter, T., Ryan, J.P., Keelan, J.A., Nathan, E., Hart, R.J., In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum Reprod 30 (2015), 88–96.
12. 12 Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004), 19–25.
13. 13 Cooper, T.G., Noonan, E., von Eckardstein, S., Auger, J., Baker, H.W., Behre, H.M., et al. World Health Organization reference values for human semen characteristics. Hum Reprod Update 16 (2010), 231–245.
14. 14 Balaban, B., Brison, D., Calderón, G., Catt, J., Conaghan, J., Cowan, L., et al. Alpha Scientists in Reproductive Medicine, ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26 (2011), 1270–1283.
15. 15 Gardner, D.K., Schoolcraft, W.B., In vitro culture of human blastocysts. Jansen, R., Mortimer, D., (eds.) Toward reproductive certainty: fertility and genetics beyond, 1999, Parthenon, Carnforth, U.K, 378–388.
16. 16 Zegers-Hochschild, F., Adamson, G.D., de Mouzon, J., Ishihara, O., Mansour, R., Nygren, K., et al. International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009. Fertil Steril 92 (2009), 1520–1524.
17. 17 Ciray, H.N., Campbell, A., Agerholm, I.E., Aguilar, J., Chamayou, S., Esbert, M., et al. Proposed guidelines on the nomenclature and annotation of dynamic human embryo monitoring by a time-lapse user group. Hum Reprod 29 (2014), 2650–2660.
18. 18 Marcus, R., Peritz, E., Gabriel, K.R., Closed testing procedures with special reference to ordered analysis of variance. Biometrika 63 (1976), 655–660.
19. 19 Walls, M.L., Ryan, J.P., Keelan, J.A., Hart, R., In vitro maturation is associated with increased early embryo arrest without impairing morphokinetic development of useable embryos progressing to blastocysts. Hum Reprod 30 (2015), 1842–1849.
20. 20 Child, T.J., Phillips, S.J., Abdul-Jalil, A.K., Gulekli, B., Tan, S.L., A comparison of in vitro maturation and in vitro fertilization for women with polycystic ovaries. Obstet Gynecol 100 (2002), 665–670.
21. 21 Gremeau, A.S., Andreadis, N., Fatum, M., Craig, J., Turner, K., McVeigh, E., et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril 98 (2012), 355–360.
22. 22 Braude, P., Bolton, V., Moore, S., Human gene expression first occurs between the four- and eight-cell stages of preimplantation development. Nature 332 (1988), 459–461.
23. 23 Son, W.Y., Lee, S.Y., Lim, J.H., Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles. Hum Reprod 20 (2005), 3204–3207.
24. 24 Coticchio, G., Guglielmo, M.C., dal Canto, M., Fadini, R., Mignini Renzini, M., de Ponti, E., et al. Mechanistic foundations of the metaphase II spindle of human oocytes matured in vivo and in vitro. Hum Reprod 28 (2013), 3271–3282.
25. 25 Hashimoto, S., Kato, N., Saeki, K., Morimoto, Y., Selection of high-potential embryos by culture in poly(dimethylsiloxane) microwells and time-lapse imaging. Fertil Steril 97 (2012), 332–337.
26. 26 Cruz, M., Garrido, N., Herrero, J., Perez-Cano, I., Munoz, M., Meseguer, M., Timing of cell division in human cleavage-stage embryos is linked with blastocyst formation and quality. Reprod Biomed Online 25 (2012), 371–381.
27. 27 Wong, C.C., Loewke, K.E., Bossert, N.L., Behr, B., De Jonge, C.J., Baer, T.M., et al. Noninvasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage. Nat Biotechnol 28 (2010), 1115–1121.
28. 28 dal Canto, M., Coticchio, G., Mignini Renzini, M., de Ponti, E., Novara, P.V., Brambillasca, F., et al. Cleavage kinetics analysis of human embryos predicts development to blastocyst and implantation. Reprod Biomed Online 25 (2012), 474–480.
29. 29 Campbell, A., Fishel, S., Bowman, N., Duffy, S., Sedler, M., Hickman, C.F., Modelling a risk classification of aneuploidy in human embryos using noninvasive morphokinetics. Reprod Biomed Online 26 (2013), 477–485.
30. 30 Deutsches IVF-Register. Deutsches IVF-Register—jahrbuch 2012. J Reprod Med Endocrinol, 2012 Sonderheft 2:1–48.
31. 31 Deutsches IVF-Register. Deutsches IVF-Register—jahrbuch 2013. J Reprod Med Endocrinol 5–6 (2013), 239–273.
32. 32 Deutsches IVF-Register. Deutsches IVF-Register—jahrbuch 2014. J Reprod Med Endocrinol 6 (2014), 511–545.
33. 33 Chen, Z., Robbins, K.M., Wells, K.D., Rivera, R.M., Large offspring syndrome: a bovine model for the human loss-of-imprinting overgrowth syndrome Beckwith-Wiedemann. Epigenetics 8 (2013), 591–601.
34. 34 Requena, A., Bronet, F., Guillen, A., Agudo, D., Bou, C., Garcia-Velasco, J.A., The impact of in-vitro maturation of oocytes on aneuploidy rate. Reprod Biomed Online 18 (2009), 777–783.
35. 35 Zhang, X.Y., Ata, B., Son, W.Y., Buckett, W.M., Tan, S.L., Ao, A., Chromosome abnormality rates in human embryos obtained from in-vitro maturation and IVF treatment cycles. Reprod Biomed Online 21 (2010), 552–559.
36. 36 Kuhtz, J., Romero, S., de Vos, M., Smitz, J., Haaf, T., Anckaert, E., Human in vitro oocyte maturation is not associated with increased imprinting error rates at LIT1, SNRPN, PEG3 and GTL2. Hum Reprod 29 (2014), 1995–2005.
37. 37 Pliushch, G., Schneider, E., Schneider, T., El Hajj, N., Rosner, S., Strowitzki, T., et al. In vitro maturation of oocytes is not associated with altered deoxyribonucleic acid methylation patterns in children from in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 103 (2015), 720–727.e1.
38. 38 Buckett, W.M., Chian, R.C., Holzer, H., Dean, N., Usher, R., Tan, S.L., Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstetrics Gynecol 110 (2007), 885–891.
39. 39 Cha, K.Y., Chung, H.M., Lee, D.R., Kwon, H., Chung, M.K., Park, L.S., et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization–embryo transfer. Fertil Steril 83 (2005), 1461–1465.
40. 40 Fadini, R., Mignini Renzini, M., Guarnieri, T., Dal Canto, M., De Ponti, E., Sutcliffe, A., et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod 27 (2012), 3601–3608.
41. 41 Foix–l'Helias, L., Grynberg, M., Ducot, B., Frydman, N., Kerbrat, V., Bouyer, J., et al. Growth development of French children born after in vitro maturation. PLoS One, 9, 2014, e89713.
42. 42 Shu-Chi, M., Jiann-Loung, H., Yu-Hung, L., Tseng-Chen, S., Ming, I.L., Tsu-Fuh, Y., Growth and development of children conceived by in-vitro maturation of human oocytes. Early Hum Dev 82 (2006), 677–682.
43. 43 Söderstrom-Anttila, V., Salokorpi, T., Pihlaja, M., Serenius-Sirve, S., Suikkari, A.M., Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod 21 (2006), 1508–1513.
44. 44 Sauerbrun-Cutler, M.T., Vega, M., Keltz, M., McGovern, P.G., In vitro maturation and its role in clinical assisted reproductive technology. Obstet Gynecol Surv 70 (2015), 45–57.